Detalhe da pesquisa
1.
Sustained Carbohydrate Antigen 19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival.
Oncologist
; 25(10): 859-866, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32277842
2.
A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma.
Oncologist
; 25(10): e1446-e1450, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452588
3.
Multi-omic molecular comparison of primary versus metastatic pancreatic tumours.
Br J Cancer
; 121(3): 264-270, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292535
4.
Pancreas Cancer-Associated Weight Loss.
Oncologist
; 24(5): 691-701, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30591550
5.
Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy.
Clin Proteomics
; 16: 31, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346328
6.
Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improved Survival?
Ann Surg Oncol
; 25(4): 1052-1060, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29344878
7.
Initiation of adjuvant therapy following surgical resection of pancreatic ductal adenocarcinoma (PDAC): Are patients from rural, remote areas disadvantaged?
J Surg Oncol
; 117(8): 1655-1663, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761510
8.
Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenocarcinoma?
HPB (Oxford)
; 20(10): 925-931, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29753633
9.
Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics.
Cancer
; 123(19): 3843-3854, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28558150
10.
Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective.
Ann Surg Oncol
; 24(6): 1722-1730, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28054192
11.
Interferon-based Adjuvant Chemoradiation for Resected Pancreatic Head Cancer: Long-term Follow-up of the Virginia Mason Protocol.
Ann Surg
; 263(2): 376-84, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25775069
12.
Pancreatic cancer: new approaches to drug therapy.
Int J Surg
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573111
13.
Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.
Am J Clin Pathol
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642081
14.
Alternating Gemcitabine/Nab-Paclitaxel (GA) and 5-FU/Leucovorin/Irinotecan (FOLFIRI) as First-Line Treatment for De Novo Metastatic Pancreatic Cancer (MPC): Safety and Effect.
Cancers (Basel)
; 15(23)2023 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38067292
15.
A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.
Cancer Med
; 11(22): 4169-4181, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499204
16.
Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.
Ann Surg Oncol
; 18(2): 337-44, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20811779
17.
Afferent limb syndrome and delayed GI problems after pancreaticoduodenectomy for pancreatic cancer: single-center, 14-year experience.
Gastrointest Endosc
; 74(2): 295-302, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21689816
18.
Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing.
Clin Cancer Res
; 26(1): 18-24, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558477
19.
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study).
Clin Cancer Res
; 25(18): 5493-5502, 2019 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31126960
20.
Strength of the evidence: adjuvant therapy for resected pancreatic cancer.
J Gastrointest Surg
; 12(4): 657-61, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18157582